Role of Siglecs in viral infections: A double-edged sword interaction.


Journal

Molecular aspects of medicine
ISSN: 1872-9452
Titre abrégé: Mol Aspects Med
Pays: England
ID NLM: 7603128

Informations de publication

Date de publication:
04 2023
Historique:
received: 28 05 2022
revised: 25 07 2022
accepted: 01 08 2022
pubmed: 19 8 2022
medline: 9 2 2023
entrez: 18 8 2022
Statut: ppublish

Résumé

Sialic-acid-binding immunoglobulin-like lectins are cell surface immune receptors known as Siglecs that play a paramount role as modulators of immunity. In recent years, research has underscored how the underlaying biology of this family of receptors influences the outcome of viral infections. While Siglecs are needed to promote effective antiviral immune responses, they can also pave the way to viral dissemination within tissues. Here, we review how recent preclinical findings focusing on the interplay between Siglecs and viruses may translate into promising broad-spectrum therapeutic interventions or key biomarkers to monitor the course of viral infections.

Identifiants

pubmed: 35981912
pii: S0098-2997(22)00058-9
doi: 10.1016/j.mam.2022.101113
pmc: PMC9923124
pii:
doi:

Substances chimiques

Sialic Acid Binding Immunoglobulin-like Lectins 0

Types de publication

Journal Article Review Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101113

Subventions

Organisme : NIAID NIH HHS
ID : UM1 AI164561
Pays : United States

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors are inventors of distinct patent applications based on Siglec-1 interactions with enveloped viruses. This review was written in the absence of any other competing interest.

Références

Nat Rev Immunol. 2002 Aug;2(8):569-79
pubmed: 12154376
Retrovirology. 2013 Dec 13;10:154
pubmed: 24330394
EMBO J. 1994 Oct 3;13(19):4490-503
pubmed: 7925291
Nature. 2021 Oct;598(7880):342-347
pubmed: 34464958
Nat Med. 2006 Dec;12(12):1365-71
pubmed: 17115046
Nat Rev Immunol. 2014 Oct;14(10):653-66
pubmed: 25234143
Cell Host Microbe. 2021 Jul 14;29(7):1093-1110
pubmed: 34242582
Nat Microbiol. 2019 Sep;4(9):1558-1570
pubmed: 31160823
JCI Insight. 2019 Jan 10;4(1):
pubmed: 30626757
J Infect Dis. 2021 Feb 24;223(4):562-567
pubmed: 33206973
Virology. 2016 Oct;497:328-336
pubmed: 27521724
J Biol Chem. 2015 Aug 7;290(32):19833-43
pubmed: 26105052
Nature. 2007 Nov 1;450(7166):110-4
pubmed: 17934446
Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):866-71
pubmed: 20080767
J Biol Chem. 2007 Feb 9;282(6):3418-22
pubmed: 17138568
Science. 2003 May 23;300(5623):1295-7
pubmed: 12730499
Eur J Biochem. 2001 Dec;268(23):6083-96
pubmed: 11733002
J Immunol. 2012 May 1;188(9):4690-700
pubmed: 22467657
J Mol Med (Berl). 2013 Feb;91(2):261-70
pubmed: 22945238
J Biomed Sci. 2020 Jan 3;27(1):10
pubmed: 31900164
Cytometry A. 2021 May;99(5):466-471
pubmed: 33547747
Int Arch Allergy Immunol. 2019;180(2):91-102
pubmed: 31401630
Annu Rev Immunol. 2012;30:357-92
pubmed: 22224769
EMBO J. 1991 Jul;10(7):1661-9
pubmed: 2050106
J Clin Invest. 2021 Jun 1;131(11):
pubmed: 34060491
J Clin Invest. 2005 Nov;115(11):3265-75
pubmed: 16224540
J Neurochem. 2007 Mar;100(6):1431-48
pubmed: 17241126
Front Cell Infect Microbiol. 2020 Feb 28;10:70
pubmed: 32181159
Inflamm Allergy Drug Targets. 2014;13(5):299-304
pubmed: 25198705
PLoS Pathog. 2013 Mar;9(3):e1003232
pubmed: 23555248
Front Immunol. 2017 Jul 13;8:819
pubmed: 28751894
PLoS Biol. 2012;10(4):e1001315
pubmed: 22545022
PLoS Pathog. 2016 Dec 8;12(12):e1006031
pubmed: 27930745
J Clin Invest. 2011 Jul;121(7):2614-24
pubmed: 21633172
Scand J Immunol. 2016 Sep;84(3):182-90
pubmed: 27312286
Nat Commun. 2022 Feb 3;13(1):679
pubmed: 35115549
EMBO J. 2017 Mar 15;36(6):751-760
pubmed: 28100677
Proc Natl Acad Sci U S A. 2022 Jan 18;119(3):
pubmed: 35031565
PLoS Pathog. 2022 Oct 24;18(10):e1010479
pubmed: 36279285
Infect Genet Evol. 2019 Jul;71:76-81
pubmed: 30898644
Blood. 1998 Sep 15;92(6):2123-32
pubmed: 9731071
PLoS One. 2011;6(9):e24559
pubmed: 21931755
J Neuroimmunol. 2004 Dec;157(1-2):93-8
pubmed: 15579285
PLoS Pathog. 2014 Nov 20;10(11):e1004509
pubmed: 25412102
Glycobiology. 2007 Aug;17(8):838-46
pubmed: 17483134
Cell Rep. 2015 Sep 29;12(12):2111-20
pubmed: 26365189
Virology. 2001 May 25;284(1):20-5
pubmed: 11352664
PLoS One. 2008 Apr 16;3(4):e1967
pubmed: 18414664
Front Immunol. 2018 May 30;9:1124
pubmed: 29899741
Front Immunol. 2019 Apr 30;10:825
pubmed: 31114569
Cell Death Dis. 2016 Nov 3;7(11):e2446
pubmed: 27809306
J Exp Med. 1999 Sep 20;190(6):793-802
pubmed: 10499918
Blood. 2007 Feb 1;109(3):1061-8
pubmed: 17008544
J Infect Dis. 1999 Feb;179 Suppl 1:S188-91
pubmed: 9988183
J Gen Virol. 2017 Aug;98(8):2030-2042
pubmed: 28742001
N Engl J Med. 2014 Dec 18;371(25):2394-401
pubmed: 25337633
Front Immunol. 2021 Mar 10;12:650331
pubmed: 33777047
J Biol Chem. 2001 Oct 26;276(43):40282-7
pubmed: 11546777
Viruses. 2019 Apr 23;11(4):
pubmed: 31018522
J Biol Chem. 1999 Aug 6;274(32):22729-38
pubmed: 10428856
PLoS One. 2014 Sep 17;9(9):e106239
pubmed: 25230315
Nature. 2022 Jun;606(7914):585-593
pubmed: 35483404
Cell Mol Immunol. 2021 Dec;18(12):2676-2678
pubmed: 34782760
Traffic. 2011 Dec;12(12):1702-13
pubmed: 21917091
Clin Microbiol Infect. 2018 Jun;24 Suppl 2:S83-S94
pubmed: 29572070
J Exp Med. 2002 May 6;195(9):1199-205
pubmed: 11994425
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2641-6
pubmed: 16481622
Immun Inflamm Dis. 2020 Mar;8(1):106-123
pubmed: 32031762
J Virol. 2013 Mar;87(6):3361-75
pubmed: 23302871
Biochem Biophys Res Commun. 2022 Jun 4;607:67-72
pubmed: 35367830
PLoS Pathog. 2013;9(4):e1003291
pubmed: 23593001
N Engl J Med. 2019 Dec 12;381(24):2293-2303
pubmed: 31774950
Biochemistry (Mosc). 2021 Mar;86(3):257-261
pubmed: 33838638
J Exp Med. 2002 Mar 4;195(5):593-602
pubmed: 11877482
Science. 2000 Oct 6;290(5489):84-9
pubmed: 11021804
Blood. 2009 Oct 29;114(18):3822-30
pubmed: 19710502
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15812-7
pubmed: 14668432
Gut. 2016 Dec;65(12):1998-2006
pubmed: 26674359
Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21685-21693
pubmed: 31591213
Blood Adv. 2019 Aug 13;3(15):2317-2322
pubmed: 31387880
PLoS One. 2012;7(6):e39039
pubmed: 22723922
Vet Res. 2018 Jul 18;49(1):67
pubmed: 30021620
J Allergy Clin Immunol. 2014 Jul;134(1):230-3
pubmed: 24810846
Annu Rev Pathol. 2017 Jan 24;12:387-418
pubmed: 27959626
PLoS Biol. 2012;10(12):e1001448
pubmed: 23271952
Histochem Cell Biol. 2017 May;147(5):565-574
pubmed: 28012129
J Exp Med. 2014 Jun 2;211(6):1231-42
pubmed: 24799499
J Biol Chem. 1999 Nov 26;274(48):34089-95
pubmed: 10567377
Sci Rep. 2017 Apr 05;7:45319
pubmed: 28378743
Retrovirology. 2015 May 07;12:37
pubmed: 25947229
Blood. 2009 Mar 19;113(12):2732-41
pubmed: 18945959
PLoS Pathog. 2021 Nov 11;17(11):e1010034
pubmed: 34762717
Eur J Immunol. 2005 Jan;35(1):243-51
pubmed: 15597323
Nature. 2011 May 25;474(7353):654-7
pubmed: 21613998
FASEB J. 2006 Oct;20(12):1964-73
pubmed: 17012248
J Immunol. 2004 Dec 1;173(11):6841-9
pubmed: 15557178
Nat Rev Immunol. 2009 Aug;9(8):581-93
pubmed: 19498381
Blood. 2001 Jan 1;97(1):288-96
pubmed: 11133773
Virology. 2003 Jan 5;305(1):115-23
pubmed: 12504546
J Leukoc Biol. 1999 Nov;66(5):705-11
pubmed: 10577497
Cell Rep. 2020 Apr 28;31(4):107569
pubmed: 32348760
Science. 2009 Mar 27;323(5922):1722-5
pubmed: 19264983
Science. 2015 Oct 30;350(6260):563-567
pubmed: 26429886
J Biol Chem. 2000 Mar 24;275(12):8625-32
pubmed: 10722702
J Biol Chem. 2000 Jul 21;275(29):22121-6
pubmed: 10801862
J Immunol. 2021 Aug 15;207(4):1018-1032
pubmed: 34330755
Proc Natl Acad Sci U S A. 2012 May 8;109(19):7475-80
pubmed: 22529395
Nature. 2010 Jun 24;465(7301):1079-83
pubmed: 20577213
J Virol. 2017 Oct 13;91(21):
pubmed: 28794041
J Virol. 2000 Apr;74(7):3264-72
pubmed: 10708443
ACS Appl Mater Interfaces. 2022 Jan 19;14(2):2488-2500
pubmed: 34995059
Nat Commun. 2016 Aug 11;7:12412
pubmed: 27510803
J Biol Chem. 2001 Jul 27;276(30):28106-12
pubmed: 11358961
Am J Pathol. 2003 Dec;163(6):2347-70
pubmed: 14633608
Nature. 2011 Jun 29;474(7353):658-61
pubmed: 21720370
Sci Transl Med. 2019 Jun 12;11(496):
pubmed: 31189718
Curr Top Microbiol Immunol. 2017;411:323-352
pubmed: 28601947
PLoS Pathog. 2012;8(12):e1003065
pubmed: 23271969
Blood. 2007 Jun 15;109(12):5337-45
pubmed: 17339424
Curr Opin Chem Biol. 2021 Jun;62:34-42
pubmed: 33607404
J Infect Dis. 2003 Dec 1;188(11):1630-8
pubmed: 14639532
J Biol Chem. 2015 Nov 6;290(45):27345-27359
pubmed: 26370074
N Engl J Med. 2020 Jun 11;382(24):2327-2336
pubmed: 32275812
Science. 1992 Jul 17;257(5068):383-7
pubmed: 1352913
J Virol. 2014 Aug;88(16):8813-25
pubmed: 24872578
Cell. 2013 Jan 31;152(3):467-78
pubmed: 23374343
Angew Chem Int Ed Engl. 2020 Dec 21;59(52):23763-23771
pubmed: 32915505
Nat Immunol. 2021 Mar;22(3):381-390
pubmed: 33589816
Cell Rep. 2018 Feb 6;22(6):1484-1495
pubmed: 29425504
Biochem J. 2001 Apr 15;355(Pt 2):489-97
pubmed: 11284738
Blood. 2006 Mar 1;107(5):1996-2003
pubmed: 16254138
Cell Host Microbe. 2019 Jan 9;25(1):87-100.e10
pubmed: 30595553
ACS Cent Sci. 2021 Apr 28;7(4):650-657
pubmed: 34056095
Nat Rev Immunol. 2007 Apr;7(4):255-66
pubmed: 17380156
Cells. 2020 Dec 24;10(1):
pubmed: 33374255
Cytogenet Cell Genet. 1997;78(3-4):295-300
pubmed: 9465907
Cell Immunol. 2007 Nov-Dec;250(1-2):91-104
pubmed: 18331725
Immunobiology. 2004;209(1-2):199-207
pubmed: 15481154
mSphere. 2021 Jun 30;6(3):e0050521
pubmed: 34160241
PLoS Pathog. 2008 Aug 22;4(8):e1000134
pubmed: 18725936

Auteurs

Dàlia Raïch-Regué (D)

IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, 08916, Badalona, Spain.

Patricia Resa-Infante (P)

IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, 08916, Badalona, Spain; University of Vic-Central University of Catalonia (UVic-UCC), 08500, Vic, Spain.

Marçal Gallemí (M)

IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, 08916, Badalona, Spain.

Fernando Laguia (F)

IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, 08916, Badalona, Spain.

Xabier Muñiz-Trabudua (X)

IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, 08916, Badalona, Spain.

Jordana Muñoz-Basagoiti (J)

IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, 08916, Badalona, Spain.

Daniel Perez-Zsolt (D)

IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, 08916, Badalona, Spain.

Jakub Chojnacki (J)

IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, 08916, Badalona, Spain; Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, 08916, Badalona, Spain.

Susana Benet (S)

Fundació lluita contra la SIDA, Infectious Diseases Department, Hospital Germans Trias i Pujol, 08916, Badalona, Spain.

Bonaventura Clotet (B)

IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, 08916, Badalona, Spain; University of Vic-Central University of Catalonia (UVic-UCC), 08500, Vic, Spain; Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, 08916, Badalona, Spain; Fundació lluita contra la SIDA, Infectious Diseases Department, Hospital Germans Trias i Pujol, 08916, Badalona, Spain; Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029, Madrid, Spain.

Javier Martinez-Picado (J)

IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, 08916, Badalona, Spain; University of Vic-Central University of Catalonia (UVic-UCC), 08500, Vic, Spain; Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, 08916, Badalona, Spain; Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029, Madrid, Spain; Catalan Institution for Research and Advanced Studies (ICREA), 08010, Barcelona, Spain.

Nuria Izquierdo-Useros (N)

IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, 08916, Badalona, Spain; Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, 08916, Badalona, Spain; Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029, Madrid, Spain. Electronic address: nizquierdo@irsicaixa.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH